These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15777909)

  • 1. Cervical softening with vaginal misoprostol before intrauterine device insertion.
    Li YT; Kuo TC; Kuan LC; Chu YC
    Int J Gynaecol Obstet; 2005 Apr; 89(1):67-8. PubMed ID: 15777909
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of oral and vaginal misoprostol for cervical ripening before evacuation of first trimester missed miscarriage.
    Jabir M; Smeet RI
    Saudi Med J; 2009 Jan; 30(1):82-7. PubMed ID: 19139779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study.
    Kalams SA; Rogers LM; Smith RM; Barnett L; Crumbo K; Sumner S; Prashad N; Rybczyk K; Milne G; Dowd SE; Chong E; Winikoff B; Aronoff DM
    Eur J Contracept Reprod Health Care; 2016 Dec; 21(6):436-442. PubMed ID: 27636701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracervical sodium nitroprusside versus vaginal misoprostol in first trimester surgical termination of pregnancy: a randomized double-blinded controlled trial.
    Chan CC; Tang OS; Ng EH; Li CF; Ho PC
    Hum Reprod; 2005 Mar; 20(3):829-33. PubMed ID: 15608034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of misoprostol in the termination of missed abortion].
    Szymańska M; Suchońska B; Ziółkowska K; Bablok L
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):307-12. PubMed ID: 15537276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical priming with misoprostol for the termination of cesarean scar pregnancy.
    Lin CH; Yu MH; Chang FW
    Taiwan J Obstet Gynecol; 2014 Mar; 53(1):109-11. PubMed ID: 24767660
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaginal misoprostol for cervical priming before dilatation and curettage in postmenopausal women: a randomized controlled trial.
    Bunnasathiansri S; Herabutya Y; O-Prasertsawat P
    J Obstet Gynaecol Res; 2004 Jun; 30(3):221-5. PubMed ID: 15210047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate and misoprostol for abortion.
    Med Lett Drugs Ther; 1996 Apr; 38(973):39-40. PubMed ID: 8602122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2004 Jan; 190(1):55-9. PubMed ID: 14749635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of misoprostol in nonpregnant women: review article.
    Choksuchat C
    J Minim Invasive Gynecol; 2010; 17(4):449-55. PubMed ID: 20621008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester.
    Tang OS; Mok KH; Ho PC
    Hum Reprod; 2004 May; 19(5):1101-4. PubMed ID: 15070888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial.
    Sääv I; Aronsson A; Marions L; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2007 Oct; 22(10):2647-52. PubMed ID: 17652452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes with same-day cervical preparation with Dilapan-S osmotic dilators and vaginal misoprostol before dilatation and evacuation at 18 to 21+6 weeks' gestation.
    Lyus R; Lohr PA; Taylor J; Morroni C
    Contraception; 2013 Jan; 87(1):71-5. PubMed ID: 22898362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety and efficacy of intravaginal misoprostol for cervical ripening in the third trimester of pregnancy].
    Wang Z; Li W; Ouyang W
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):326-8. PubMed ID: 9596908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the prostaglandin E analogue Misoprostol and follicle-stimulating hormone on cervical penetrability in ewes during the peri-ovulatory period.
    Leethongdee S; Khalid M; Bhatti A; Ponglowhapan S; Kershaw CM; Scaramuzzi RJ
    Theriogenology; 2007 Mar; 67(4):767-77. PubMed ID: 17126896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology of misoprostol (pharmacokinetic data, adverse effects and teratogenic effects)].
    Aubert J; Bejan-Angoulvant T; Jonville-Bera AP
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):114-22. PubMed ID: 24440131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical preparation for surgical abortion between 12 and 18 weeks of gestation using vaginal misoprostol and Dilapan-S.
    Wilson LC; Meyn LA; Creinin MD
    Contraception; 2011 Jun; 83(6):511-6. PubMed ID: 21570547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical softening with vaginal misoprostol before hysterosalpingography.
    Li YT; Chen TH; Kuo TC
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):130-1. PubMed ID: 16934383
    [No Abstract]   [Full Text] [Related]  

  • 19. Misoprostol use for cervical ripening and induction of labour in a Nigerian teaching hospital.
    Ekele BA; Nnadi DC; Gana MA; Shehu CE; Ahmed Y; Nwobodo EI
    Niger J Clin Pract; 2007 Sep; 10(3):234-7. PubMed ID: 18072452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.